293 related articles for article (PubMed ID: 27184399)
1. Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program.
Valle JA; O'Donnell CI; Armstrong EJ; Bradley SM; Maddox TM; Ho PM
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27184399
[TBL] [Abstract][Full Text] [Related]
2. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
[TBL] [Abstract][Full Text] [Related]
3. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
4. Guideline-Based Medications for Older Adults Discharged after Percutaneous Coronary Intervention in a Suburban City of Japan: A Cohort Study Using Claims Data.
Shimada K; Hamada S; Sawano M; Yamamoto H; Yoshie S; Iijima K; Miyata H
Tohoku J Exp Med; 2020 Oct; 252(2):143-152. PubMed ID: 33028759
[TBL] [Abstract][Full Text] [Related]
5. Effect of obesity on in-hospital treatment for acute coronary syndrome complicated by new-onset heart failure.
Wu AH; Eagle KA; Froehlich JB; Montgomery DG; Kline-Rogers E; Aaronson KD
Coron Artery Dis; 2013 Jun; 24(4):279-84. PubMed ID: 23511946
[TBL] [Abstract][Full Text] [Related]
6. Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease.
Ladapo JA; Hoffmann U; Lee KL; Coles A; Huang M; Mark DB; Dolor RJ; Pelberg RA; Budoff M; Sigurdsson G; Severance HW; Douglas PS
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27733347
[TBL] [Abstract][Full Text] [Related]
7. Practice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario.
Garg P; Wijeysundera HC; Yun L; Cantor WJ; Ko DT
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25122664
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary Intervention.
Lapa ME; Swabe GM; Rollman BL; Muldoon MF; Thurston RC; Magnani JW
JAMA Netw Open; 2022 Dec; 5(12):e2246317. PubMed ID: 36508214
[TBL] [Abstract][Full Text] [Related]
9. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease.
Hira RS; Kataruka A; Akeroyd JM; Ramsey DJ; Pokharel Y; Gurm HS; Nasir K; Deswal A; Jneid H; Alam M; Ballantyne CM; Petersen LA; Virani SS
Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004817. PubMed ID: 30636483
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
[TBL] [Abstract][Full Text] [Related]
11. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
12. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
14. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.
Tjia J; Briesacher BA
J Am Geriatr Soc; 2008 Oct; 56(10):1879-86. PubMed ID: 18771456
[TBL] [Abstract][Full Text] [Related]
15. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
[TBL] [Abstract][Full Text] [Related]
16. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.
Lancefield T; Clark DJ; Andrianopoulos N; Brennan AL; Reid CM; Johns J; Freeman M; Charter K; Duffy SJ; Ajani AE; Proietto J; Farouque O;
JACC Cardiovasc Interv; 2010 Jun; 3(6):660-8. PubMed ID: 20630460
[TBL] [Abstract][Full Text] [Related]
17. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Medication Use and Long-Term Outcomes of First Nations and Non-First Nations Patients Following Diagnostic Angiography: A Retrospective Cohort Study.
Dahl L; Schultz A; McGibbon E; Brownlie J; Cook C; Elbarouni B; Katz A; Nguyen T; Sawatzky JA; Sinclaire M; Throndson K; Prior HJ; Fransoo R
J Am Heart Assoc; 2019 Aug; 8(16):e012040. PubMed ID: 31405352
[TBL] [Abstract][Full Text] [Related]
19. Association of Body Mass Index and Extreme Obesity With Long-Term Outcomes Following Percutaneous Coronary Intervention.
Biswas S; Andrianopoulos N; Dinh D; Duffy SJ; Lefkovits J; Brennan A; Noaman S; Ajani A; Clark DJ; Freeman M; Oqueli E; Hiew C; Reid CM; Stub D; Chan W
J Am Heart Assoc; 2019 Nov; 8(21):e012860. PubMed ID: 31648578
[TBL] [Abstract][Full Text] [Related]
20. Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes.
Crosier R; Austin PC; Ko DT; Lawler PR; Stukel TA; Farkouh ME; Wang X; Spertus JA; Ross HJ; Lee DS
Am J Med; 2021 May; 134(5):672-681.e4. PubMed ID: 33181105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
